Valeant Pharmaceuticals Intl
13F holders, Q1 2024 (March 31)1holders
$10.61avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Valeant Pharmaceuticals Intl in their 13F filings. The largest holder was Bruce & Co., Inc. ($6.8M).
- Company
- Valeant Pharmaceuticals Intl
- Filed as
- Bausch Health (Q1 2024)
- CUSIP
- 91911K102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Bruce & Co., Inc. | 2.30% | No change | 644,000 | $6.8M |
"% of holder's portfolio" is VALEANT PHARMACEUTICALS INTL's weight in each manager's 13F, not the share of Valeant Pharmaceuticals Intl the manager owns.